What is NDC 0009-0856?

0009-0856 is the product NDC for Hemabate (carboprost tromethamine), Carboprost tromethamine 250 ug/mL injection, solution, listed with the FDA by Pharmacia & Upjohn Company LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

Hemabate (Carboprost tromethamine).

Pharmacia & Upjohn Company LLC, NDC labeler code 0009. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Hemabate?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Hemabate NDC 0009-0856 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)0009-0856Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00009-0856Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0009-0856-05	00009085605	1 mL in 1 AMPULE (0009-0856-05)Marketed from Jan 9, 1979
0009-0856-08	00009085608	10 AMPULE in 1 PACKAGE (0009-0856-08) / 1 mL in 1 AMPULE (0009-0856-05)Marketed from Jan 9, 1979

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Hemabate
Generic name (nonproprietary): carboprost tromethamine
Active ingredients: Carboprost tromethamine — 250 ug/mL
Dosage form: Injection, Solution
Route: Intramuscular
Labeler: Pharmacia & Upjohn Company LLCNDC labeler code 0009
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 017989
Marketing start: Jan 9, 1979
Listing expires: Dec 31, 2027
Other FDA classes: Prostaglandins (Chemical structure)
Identifiers: Product ID 0009-0856_7321f382-9653-4cdb-99ac-96384dd06abbSPL ID 7321f382-9653-4cdb-99ac-96384dd06abbSPL set ID 3d282998-ff0c-480a-bd80-155606ef0a65RxCUI 213638, 238014UNII U4526F86FJUPC 0300090856083
Pharmacologic class: Prostaglandin Analog

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N400009085605 followed by a unit qualifier and the quantity

Package 00009-0856-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 30, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE HEMABATE Sterile Solution is indicated for aborting pregnancy between the 13th and 20th weeks of gestation as calculated from the first day of the last normal menstrual period and in the following conditions related to second trimester abortion: 1. Failure of expulsion of the fetus during the course of treatment by another method; 2. Premature rupture of membranes in intrauterine methods with loss of drug and insufficient or absent uterine activity; 3. Requirement of a repeat intrauterine instillation of drug for expulsion of the fetus; 4. Inadvertent or spontaneous rupture of membranes in the presence of a previable fetus and absence of adequate activity for expulsion.…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 0009-0856

What is NDC 0009-0856?: 0009-0856 is the product NDC for Hemabate (carboprost tromethamine), Carboprost tromethamine 250 ug/mL injection, solution, listed with the FDA by Pharmacia & Upjohn Company LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Hemabate (Carboprost tromethamine).
What is the active ingredient?: Carboprost tromethamine.
Who is the labeler?: Pharmacia & Upjohn Company LLC, NDC labeler code 0009. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Hemabate?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Hemabate (Carboprost tromethamine) NDC 0009-0856